Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Nov 19 2020

Full Issue

Bill Altering Orphan Drug Act Passes House

The legislation aims to close a loophole that provides drugmakers with an extended monopoly and the opportunity for big profits on drugs for rare diseases. An orphan drug bill has also been introduced in the Senate.

Stat: House Passes Bill To Close Loophole Giving Drug Makers 'Unfair' Monopolies

Seeking to boost competition in the pharmaceutical industry, the House passed a bill that would close a loophole in a law that was meant to encourage development of rare disease drugs, but that had inadvertently precluded availability of lower-cost versions of medicines. The legislation was proposed last year after a company complained that it was unable to win approval from the Food and Drug Administration to sell an opioid addiction treatment because of a stipulation in the Orphan Drug Act. (Silverman, 11/18)

In other news from Capitol Hill —

The Hill: Senate Democrats Introduce Bill To Shore Up PPE Supply 

Senate Democrats on Wednesday introduced a bill that would shore up the supply of protective equipment for health care workers as the U.S. faces another surge of COVID-19 cases. The bill would appropriate $10 billion for the government to purchase large quantities of masks, gloves, gowns and face shields, Senate Minority Leader Charles Schumer (D-N.Y.) told reporters Wednesday. (Hellmann, 11/18)

The Hill: Bipartisan Lawmakers Call For Expedited Diabetes Research 

Lawmakers on both sides of the aisle Wednesday called for bipartisan policies to expedite diabetes research. Speaking at The Hill's Diabetes and The Future of Healthcare Reform event, Rep. Diana DeGette (D-Colo.) discussed what she saw as some of the obstacles to better care. (Baker, 11/18)

The Hill: AOC, Progressive Dems Attack Corporate Greed During Health Care Discussion 

Several progressive members of the House Democratic Caucus joined a livestreamed conversation on health care reform on Wednesday and attacked what they said was widespread greed and fraud in the pharmaceutical and health care industries. Reps. Alexandria Ocasio-Cortez (D-N.Y.), Pramila Jayapal (D-Wash.) and Katie Porter (D-Calif.) spoke at the event hosted by the left-leaning Center for Health and Democracy, where they and former Cigna executive Wendell Potter, now a "Medicare for All" advocate, discussed the state of the U.S. health care system. (Bowden, 11/18)

Also —

CNN: Two More House Members Announce They Have Covid-19

Two more House members announced Wednesday they have tested positive for Covid-19 and are isolating, the latest in a string of diagnoses that have hit Capitol Hill. The cases brings CNN's tally to 26 House members and eight senators that have so far tested positive or been presumed positive. (Diaz and Wilson, 11/18)

The Hill: Capitol's COVID-19 Spike Could Be Bad Thanksgiving Preview 

Congress is experiencing a spike in COVID-19 cases among lawmakers while doing exactly what Americans are being warned not to do for Thanksgiving this year: gathering together after traveling from all over the country. In the last week alone, seven members of Congress have tested positive for COVID-19, with three others quarantining after exposure. (Marcos, 11/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF